Semotiadil (racemate fumarate) is a novel vascular-selective Ca²⁺ channel antagonist used for the treatment of hypertension; it demonstrates antihypertensive effects when administered alone or in combination with Enalapril or trichlormethiazide, and shows potential for continuous blood pressure control, especially when co-administered with Enalapril at low doses.